Treatment of Blepharospasm and Oromandibular Dystonia with Botulinum Toxins

Blepharospasm and oromandibular dystonia are focal dystonias characterized by involuntary and often patterned, repetitive muscle contractions. There is a long history of medical and surgical therapies, with the current first-line therapy, botulinum neurotoxin (BoNT), becoming standard of care in 198...

Full description

Bibliographic Details
Main Authors: Travis J.W. Hassell, David Charles
Format: Article
Language:English
Published: MDPI AG 2020-04-01
Series:Toxins
Subjects:
Online Access:https://www.mdpi.com/2072-6651/12/4/269
_version_ 1827718265537822720
author Travis J.W. Hassell
David Charles
author_facet Travis J.W. Hassell
David Charles
author_sort Travis J.W. Hassell
collection DOAJ
description Blepharospasm and oromandibular dystonia are focal dystonias characterized by involuntary and often patterned, repetitive muscle contractions. There is a long history of medical and surgical therapies, with the current first-line therapy, botulinum neurotoxin (BoNT), becoming standard of care in 1989. This comprehensive review utilized MEDLINE and PubMed and provides an overview of the history of these focal dystonias, BoNT, and the use of toxin to treat them. We present the levels of clinical evidence for each toxin for both, focal dystonias and offer guidance for muscle and site selection as well as dosing.
first_indexed 2024-03-10T20:18:51Z
format Article
id doaj.art-e7f9de3de89b45128546d345f21cca40
institution Directory Open Access Journal
issn 2072-6651
language English
last_indexed 2024-03-10T20:18:51Z
publishDate 2020-04-01
publisher MDPI AG
record_format Article
series Toxins
spelling doaj.art-e7f9de3de89b45128546d345f21cca402023-11-19T22:21:20ZengMDPI AGToxins2072-66512020-04-0112426910.3390/toxins12040269Treatment of Blepharospasm and Oromandibular Dystonia with Botulinum ToxinsTravis J.W. Hassell0David Charles1Department of Neurology, Vanderbilt University Medical Center, 1161 21st Avenue South, Suite A-1106 MCN, Nashville, TN 37232, USADepartment of Neurology, Vanderbilt University Medical Center, 1161 21st Avenue South, Suite A-1106 MCN, Nashville, TN 37232, USABlepharospasm and oromandibular dystonia are focal dystonias characterized by involuntary and often patterned, repetitive muscle contractions. There is a long history of medical and surgical therapies, with the current first-line therapy, botulinum neurotoxin (BoNT), becoming standard of care in 1989. This comprehensive review utilized MEDLINE and PubMed and provides an overview of the history of these focal dystonias, BoNT, and the use of toxin to treat them. We present the levels of clinical evidence for each toxin for both, focal dystonias and offer guidance for muscle and site selection as well as dosing.https://www.mdpi.com/2072-6651/12/4/269blepharospasmoromandibular dystoniaMeige syndromebotulinum toxinOnabotulinumtoxinAAbobotulinumtoxinA
spellingShingle Travis J.W. Hassell
David Charles
Treatment of Blepharospasm and Oromandibular Dystonia with Botulinum Toxins
Toxins
blepharospasm
oromandibular dystonia
Meige syndrome
botulinum toxin
OnabotulinumtoxinA
AbobotulinumtoxinA
title Treatment of Blepharospasm and Oromandibular Dystonia with Botulinum Toxins
title_full Treatment of Blepharospasm and Oromandibular Dystonia with Botulinum Toxins
title_fullStr Treatment of Blepharospasm and Oromandibular Dystonia with Botulinum Toxins
title_full_unstemmed Treatment of Blepharospasm and Oromandibular Dystonia with Botulinum Toxins
title_short Treatment of Blepharospasm and Oromandibular Dystonia with Botulinum Toxins
title_sort treatment of blepharospasm and oromandibular dystonia with botulinum toxins
topic blepharospasm
oromandibular dystonia
Meige syndrome
botulinum toxin
OnabotulinumtoxinA
AbobotulinumtoxinA
url https://www.mdpi.com/2072-6651/12/4/269
work_keys_str_mv AT travisjwhassell treatmentofblepharospasmandoromandibulardystoniawithbotulinumtoxins
AT davidcharles treatmentofblepharospasmandoromandibulardystoniawithbotulinumtoxins